These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35764288)

  • 1. Clinical and Economic Burden of Multiple Double-Stranded DNA Viral Infections after Allogeneic Hematopoietic Cell Transplantation.
    Hill JA; Moon SH; Chandak A; Zhang Z; Boeckh M; Maziarz RT
    Transplant Cell Ther; 2022 Sep; 28(9):619.e1-619.e8. PubMed ID: 35764288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States.
    McGuirk J; Divine C; Moon SH; Chandak A; Zhang Z; Papanicolaou GA
    Transplant Cell Ther; 2021 Jun; 27(6):505.e1-505.e9. PubMed ID: 33775616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality.
    Hill JA; Mayer BT; Xie H; Leisenring WM; Huang ML; Stevens-Ayers T; Milano F; Delaney C; Sorror ML; Sandmaier BM; Nichols G; Zerr DM; Jerome KR; Schiffer JT; Boeckh M
    Blood; 2017 Apr; 129(16):2316-2325. PubMed ID: 28209721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-Infections by Double-Stranded DNA Viruses after Ex Vivo T Cell-Depleted, CD34
    Huang YT; Kim SJ; Lee YJ; Burack D; Nichols P; Maloy M; Perales MA; Giralt SA; Jakubowski AA; Papanicolaou GA
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1759-1766. PubMed ID: 28668490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic and clinical burden associated with respiratory viral infections after allogeneic hematopoietic cell transplant in the United States.
    Ison MG; Marty FM; Chao N; Moon SH; Zhang Z; Chandak A
    Transpl Infect Dis; 2022 Aug; 24(4):e13866. PubMed ID: 35598293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.
    Ding Y; Ru Y; Song T; Guo L; Zhang X; Zhu J; Li C; Jin Z; Huang H; Tu Y; Xu M; Xu Y; Chen J; Wu D
    Ann Hematol; 2021 Nov; 100(11):2773-2785. PubMed ID: 34480615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - A single center 11-year analysis.
    Düver F; Weißbrich B; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
    PLoS One; 2020; 15(2):e0228451. PubMed ID: 32017805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of Double-Stranded DNA Viremia After Allogeneic Hematopoietic Cell Transplantation.
    Hill JA; Mayer BT; Xie H; Leisenring WM; Huang ML; Stevens-Ayers T; Milano F; Delaney C; Jerome KR; Zerr DM; Nichols G; Boeckh M; Schiffer JT
    Clin Infect Dis; 2018 Jan; 66(3):368-375. PubMed ID: 29020348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical Study of Allogeneic Hematopoietic Stem Cell Transplantation Patients with Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus].
    Wang ZW; Liu Q; Sun HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):561-567. PubMed ID: 38660867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.
    Tzannou I; Papadopoulou A; Naik S; Leung K; Martinez CA; Ramos CA; Carrum G; Sasa G; Lulla P; Watanabe A; Kuvalekar M; Gee AP; Wu MF; Liu H; Grilley BJ; Krance RA; Gottschalk S; Brenner MK; Rooney CM; Heslop HE; Leen AM; Omer B
    J Clin Oncol; 2017 Nov; 35(31):3547-3557. PubMed ID: 28783452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic Stem Cell Transplantation in Children and Young Adults.
    Galletta TJ; Lane A; Lutzko C; Leemhuis T; Cancelas JA; Khoury R; Wang YM; Hanley PJ; Keller MD; Bollard CM; Davies SM; Grimley MS; Rubinstein JD
    Transplant Cell Ther; 2023 May; 29(5):305-310. PubMed ID: 36736781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and outcome of concurrent and sequential multiviral cytomegalovirus, Epstein-Barr virus, BK virus, adenovirus and other viral reactivations in transplantation.
    Sim BZ; Yong KY; Slavin MA; Yong MK
    Curr Opin Infect Dis; 2022 Dec; 35(6):536-544. PubMed ID: 36255049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, Outcome and Risk Factors Analysis of Viral Infections in Children and Adolescents Undergoing Hematopoietic Cell Transplantation: Antiviral Drugs Do Not Prevent Epstein-Barr Virus Reactivation.
    Czyzewski K; Dziedzic M; Salamonowicz M; Fraczkiewicz J; Zajac-Spychala O; Zaucha-Prazmo A; Gozdzik J; Galazka P; Bartoszewicz N; Demidowicz E; Styczynski J
    Infect Drug Resist; 2019; 12():3893-3902. PubMed ID: 31908501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients.
    Roubalová K; Němečková Š; Kryštofová J; Hainz P; Pumannová M; Hamšíková E
    Immunol Lett; 2020 Dec; 228():64-69. PubMed ID: 33031870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experience.
    Obermaier B; Braun C; Hensen L; Ahmad O; Faul C; Lang P; Bethge W; Lengerke C; Vogel W
    Transpl Infect Dis; 2024 Aug; 26(4):e14296. PubMed ID: 38830809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for BK virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
    Zhou X; Zhang S; Fan J; Zhu X; Hu S
    Clin Transplant; 2023 Nov; 37(11):e15121. PubMed ID: 37676427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic impact of treated CMV infection in adult CMV-seropositive patients after allogeneic hematopoietic cell transplantation.
    Peffault De Latour R; Chevallier P; Blaise D; Alami S; Lévy-Bachelot L; Allavoine T; Tadmouri A; Blomkvist J; Duhamel A; Srour M; Beauvais D; Yakoub-Agha I
    J Med Virol; 2020 Dec; 92(12):3665-3673. PubMed ID: 32297984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen.
    Ru Y; Zhu J; Song T; Ding Y; Zhu Z; Fan Y; Xu Y; Sun A; Qiu H; Jin Z; Tang X; Han Y; Fu C; Chen S; Ma X; Chen F; Chen J; Wu D
    Front Cell Infect Microbiol; 2022; 12():865170. PubMed ID: 35651756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal Active Anti-Thymocyte Globulin Exposure Associated with Minimum Risk of Virus Reactivation and Comparable Acute Graft-Versus-Host Disease Under Adult Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation.
    Wang H; Zhao Y; Fang S; Wang L; Peng B; Yang J; Wang N; Du J; Li F; Jin X; Luan S; Wu X; Dou L; Liu D
    Transplant Cell Ther; 2022 Jun; 28(6):332.e1-332.e10. PubMed ID: 35314377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.